+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 19Years +
FEMALE
ID05309460

Randomized Trial Comparing Labetalol and Nifedipine for Managing Postpartum Hypertension

Led by Nebraska Methodist Health System · Updated on 2024-04-12

600

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

The trial investigates postpartum hypertension management by comparing the risk of hospital readmission and hypertensive complications in patients treated with Labetalol versus Nifedipine. It is a randomized controlled trial enrolling patients admitted for delivery at 24 weeks gestation or later who have hypertension defined by specific blood pressure thresholds. The study aims to evaluate which medication better controls postpartum hypertension and reduces readmission risks. Participants are randomly assigned to one of two treatment groups. In the Nifedipine arm, patients start on extended-release Nifedipine 30mg twice daily, with dose escalation by the primary provider up to 120mg daily. If hypertension persists, Labetalol is added. In the Labetalol arm, patients start at 200mg three times daily, with escalation up to 2400mg daily if higher doses are not tolerated due to bradycardia, Nifedipine is added. Patients are monitored for side effects and signs of low blood pressure, and hospitalization is not extended solely for study purposes. Participants undergo outpatient follow-up as directed by their care provider. At six months, researchers contact patients to check for hospital readmissions and review medical records for emergency evaluations or readmissions. The primary outcome is hospital readmission within six months. Secondary outcomes include medication failure and changes or discontinuation within six months. Safety is overseen by a monitoring board reviewing data every six months, with study termination planned if significant differences arise.

CONDITIONS

Brief Title

Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

Research Team

T

Todd Lovgren, MD

J

Joshua Dahlke, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here